1Silver J,Levi R.Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.Kidney Int,2005,(suppl95):S8-12.
2Sanchez CP,Goodman WG,Salusky IB.Prevention of renal osteodystrophy in predialysis patients.Am J Med Sci,1999,317:398-404.
3Moallem E,Kilav R,Silver J,Naveh-Many T.RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate.J Biol Chem,1998,273:5253-9.
4Ghazali A,Fardellone P,Pruna A,et al.Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int,1999,55:2169-7.
5Spasovski GB,Bervoets AR,Behets GJ,et al.Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.Nephrol Dial Transplant,2003,18(6):1159-566.
6Atsumi K,Kushida K,Yamazaki K et al.Risk factors for vertebral fractures in renal osteodystrophy.Am J Kidney Dis,1999,33:287-93.
7Pecovnik Balon B,Puklavec L,Hojs R.Comparison of the intact PTH test with the total PTH test in hemodialyzed patients.Acta Med Croatica,2003,57(1):69-70.
8Goodman WG,Goldin J,Kuizon BD,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergo ing dialysis.N Engl J Med,2000,342:1478-83.
9Bleyer A J,Burkart J,Piazza M,et al.Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD.Am J Kidney Dis,2005,46(3):464-9.
10Ganesh SK,Stack AG,Lewin NW et al.Association of elevated serum PO(4),Ca×PO(4)product,and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.J Am Soc Nephrol,2001,12:2131-8.
